Patient Square Capital Acquires Patterson Companies

Patient Square Capital Acquires Premier, Inc.

November 25, 2025

Healthcare Services

Patient Square Capital, a healthcare-focused private equity firm, is acquiring Premier, Inc. in a take-private transaction approved by Premier stockholders. Under the deal Premier stockholders will receive $28.25 per share (a ~23.8% premium) and the transaction — valued at roughly $2.6 billion — was expected to close on or about November 25, 2025.

Patient Square Capital Acquires Premier, Inc.

November 25, 2025

Healthcare Services

Patient Square Capital, a healthcare-focused investment firm, has completed its $2.6 billion acquisition of Premier, Inc. Under the deal, Premier will be taken private, delisted from Nasdaq, and Premier stockholders will receive $28.25 per share in cash. The transaction positions Patient Square to grow Premier's technology-driven data, analytics, supply chain and consulting offerings.

Patient Square Capital Acquires Hanger, Inc.

October 3, 2022

Healthcare Services

Patient Square Capital, a dedicated health care investment firm, completed an all-cash acquisition of Hanger, Inc. (NYSE: HNGR) for $18.75 per share, valuing the company at approximately $1.25 billion. Hanger — an Austin, Texas–based provider of orthotic and prosthetic (O&P) patient care services and related products with ~875 clinics nationwide — will become a private company to pursue growth and investment initiatives with its current CEO continuing to lead the business.

Gurnet Point Capital and Patient Square Capital Acquire Radius Health

June 23, 2022

Biotechnology

Gurnet Point Capital and Patient Square Capital completed a take-private acquisition of Radius Health, Inc. in a transaction valued at approximately $890 million (including debt), paying $10.00 per share in cash plus a $1.00 CVR tied to TYMLOS sales. Debt financing was provided by OrbiMed Advisors; following the transaction Radius will be delisted and will remain operating in the Boston, MA and Wayne, PA areas as a privately held biopharmaceutical company focused on bone health and neuro-orphan diseases.

Patient Square Capital Acquires SOC Telemed, Inc.

February 3, 2022

Healthcare Services

Patient Square Capital agreed to acquire SOC Telemed, Inc., the largest U.S. provider of acute care telemedicine, in an all-cash transaction valuing SOC Telemed at $3.00 per share. The deal takes SOC Telemed private and will provide capital and industry expertise to expand the company’s clinical capabilities, innovate its Telemed IQ platform and grow its footprint across hospitals, post-acute and value-based care organizations.

Patient Square Capital Makes Strategic Investment in CorroHealth; Carlyle to Share Joint Control

October 24, 2024

Healthcare Services

CorroHealth, a Plano-based provider of clinically led revenue cycle management (RCM) and healthcare analytics, has signed definitive agreements for a strategic investment from Patient Square Capital. Current shareholders including Carlyle will remain investors, and Patient Square and Carlyle will share joint control as CorroHealth pursues further organic and inorganic growth.